And hopefully RAP's has similar high sensitivity in the 90% but better specificity compared to RAT's 60-70% and the same as the massive market for acute respiratory diagnosis and chronic respiratory management, the key difference is RAP's will be cheaper and easier to use.
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-176
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online